Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease
Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...
Auteurs principaux: | A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich |
---|---|
Format: | Article |
Langue: | Russian |
Publié: |
Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
2015-09-01
|
Collection: | Проблемы особо опасных инфекций |
Sujets: | |
Accès en ligne: | https://journal.microbe.ru/jour/article/view/254 |
Documents similaires
-
Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
par: E. I. Kazachinskaya, et autres
Publié: (2015-09-01) -
“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
par: Alexey Alekseevich Andreev, et autres
Publié: (2020-06-01) -
Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
par: A. A. Petrov, et autres
Publié: (2020-05-01) -
New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
par: A. A. Sominina, et autres
Publié: (2015-10-01) -
Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
par: A. V. Philippova, et autres
Publié: (2019-10-01)